Chase Investment Counsel Corp / ABT
Chase Investment Counsel Corp’s Abbott Laboratories Position
Does Chase Investment Counsel Corp own Abbott Laboratories (ABT)? Not currently — the last reported position was 19.8K shares worth $2M in Q1 2021; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$2M
Q1 2021
Shares
19.8K
% of Portfolio
+1.08%
Quarters Held
2
position exited
Position History ABT
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Chase Investment Counsel Corp’s full portfolio or all institutional holders of ABT.